Literature DB >> 10937678

A topographic study of Helicobacter pylori density, distribution and associated gastritis.

V Misra1, S Misra, M Dwivedi, U P Singh, V Bhargava, S C Gupta.   

Abstract

BACKGROUND AND AIMS: The topographic distribution and density of Helicobacter pylori and associated gastritis in the stomach were studied in order to determine which biopsy sites are likely to provide the maximum yield so as to reduce the fallacious results due to sampling error.
METHODS: Fifty patients with upper gastrointestinal symptoms were studied. Eleven gastric biopsies from predetermined sites were obtained and subjected to ultra-rapid urease test, imprint cytology and histology. Haematoxylin and eosin stain was used for defining gastritis and other associated histopathological details. Loeffler's methylene blue stain was used to confirm the presence of H. pylori in imprint smears and histological sections.
RESULTS: All 50 patients had H. pylori infection and evidence of chronic gastritis at one or more of the 11 biopsy sites. Maximum and minimum percentage positivity were observed at A3 (antral lesser curvature) and B4 (corpus greater curvature), respectively. Various sites in decreasing order of percentage positivity were A3 > A2 > A1 > A4 > B3 > B1 > A5 > B6 > B5 > B2 > B4. Among the biopsies obtained from the corpus, B3 (corpus lesser curvature) was the site with maximum positivity. A3 and B4 had a statistically significant difference in percentage positivity (P < 0.0001) for H. pylori and gastritis. The maximum and minimum density scores of H. pylori and gastritis were found in A3 and the B4, respectively. A3 had a significantly higher (P < 0.0001) mean density score than any other site in the stomach. The difference in the grading of H. pylori between A3 and B3 (sites of maximum positivity in antrum and corpus) was statistically significant (P < 0.0001). A statistically significant (P < 0.001) positive correlation between increasing grades of H. pylori and gastritis was observed at the site of maximum density. Eighty per cent of the patients had antral predominant gastritis and in 82%, H. pylori was predominantly observed in antral biopsies.
CONCLUSION: It is concluded that two biopsies taken from A3 are sufficient for confirmation of presence of H. pylori and associated gastritis for initiation of treatment. However, additional biopsies from B3 will help in deciding the topographic pattern of gastritis.

Entities:  

Mesh:

Year:  2000        PMID: 10937678     DOI: 10.1046/j.1440-1746.2000.02240.x

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  11 in total

Review 1.  Oxyntic atrophy, metaplasia, and gastric cancer.

Authors:  James R Goldenring; Ki Taek Nam
Journal:  Prog Mol Biol Transl Sci       Date:  2010       Impact factor: 3.622

2.  Helicobacter pylori genotypes may determine gastric histopathology.

Authors:  C Nogueira; C Figueiredo; F Carneiro; A T Gomes; R Barreira; P Figueira; C Salgado; L Belo; A Peixoto; J C Bravo; L E Bravo; J L Realpe; A P Plaisier; W G Quint; B Ruiz; P Correa; L J van Doorn
Journal:  Am J Pathol       Date:  2001-02       Impact factor: 4.307

3.  Helicobacter pylori Adapts to Chronic Infection and Gastric Disease via pH-Responsive BabA-Mediated Adherence.

Authors:  Jeanna A Bugaytsova; Oscar Björnham; Yevgen A Chernov; Pär Gideonsson; Sara Henriksson; Melissa Mendez; Rolf Sjöström; Jafar Mahdavi; Anna Shevtsova; Dag Ilver; Kristof Moonens; Macarena P Quintana-Hayashi; Roman Moskalenko; Christopher Aisenbrey; Göran Bylund; Alexej Schmidt; Anna Åberg; Kristoffer Brännström; Verena Königer; Susanne Vikström; Lena Rakhimova; Anders Hofer; Johan Ögren; Hui Liu; Matthew D Goldman; Jeannette M Whitmire; Jörgen Ådén; Justine Younson; Charles G Kelly; Robert H Gilman; Abhijit Chowdhury; Asish K Mukhopadhyay; G Balakrish Nair; Konstantinos S Papadakos; Beatriz Martinez-Gonzalez; Dionyssios N Sgouras; Lars Engstrand; Magnus Unemo; Dan Danielsson; Sebastian Suerbaum; Stefan Oscarson; Ludmilla A Morozova-Roche; Anders Olofsson; Gerhard Gröbner; Jan Holgersson; Anders Esberg; Nicklas Strömberg; Maréne Landström; Angela M Eldridge; Brett A Chromy; Lori M Hansen; Jay V Solnick; Sara K Lindén; Rainer Haas; Andre Dubois; D Scott Merrell; Staffan Schedin; Han Remaut; Anna Arnqvist; Douglas E Berg; Thomas Borén
Journal:  Cell Host Microbe       Date:  2017-03-08       Impact factor: 21.023

4.  Antral exfoliative cytology for the detection of Helicobacter pylori in the stomach.

Authors:  Claudio A R Gomes; Wilson R Catapani; Ana M A A Mader; Angelo Locatelli; Claudilene B- P Silva; Jaques Waisberg
Journal:  World J Gastroenterol       Date:  2005-05-14       Impact factor: 5.742

5.  A study of Helicobacter pylori-associated gastritis patterns in Iraq and their association with strain virulence.

Authors:  Nawfal R Hussein; Sarbar M Napaki; John C Atherton
Journal:  Saudi J Gastroenterol       Date:  2009-04       Impact factor: 2.485

6.  Effect of biopsies on sensitivity and specificity of ultra-rapid urease test for detection of Helicobacter pylori infection: a prospective evaluation.

Authors:  Li-Lin Lim; Khek-Yu Ho; Bow Ho; Manuel Salto-Tellez
Journal:  World J Gastroenterol       Date:  2004-07-01       Impact factor: 5.742

Review 7.  Current understanding of SPEM and its standing in the preneoplastic process.

Authors:  Victoria G Weis; James R Goldenring
Journal:  Gastric Cancer       Date:  2010-01-05       Impact factor: 7.370

Review 8.  Helicobacter pylori detection and antimicrobial susceptibility testing.

Authors:  Francis Mégraud; Philippe Lehours
Journal:  Clin Microbiol Rev       Date:  2007-04       Impact factor: 26.132

9.  Disease manifestations of Helicobacter pylori infection in Arctic Canada: using epidemiology to address community concerns.

Authors:  Justin Cheung; Karen J Goodman; Safwat Girgis; Robert Bailey; John Morse; Richard N Fedorak; Janis Geary; Katharine Fagan-Garcia; Sander Veldhuyzen van Zanten
Journal:  BMJ Open       Date:  2014-01-08       Impact factor: 2.692

10.  Efficacy of a quadruple therapy regimen for Helicobacter pylori eradication after partial gastrectomy.

Authors:  F Zhang; Z J Bao; D M Shi; P Xiang; L Xiao; Y Q Huang; G S Zhang; S M Yin
Journal:  Braz J Med Biol Res       Date:  2016-02-05       Impact factor: 2.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.